Leuko is developing the world’s first portable, non-invasive white blood cell monitoring device to screen for severe neutropenia. In May 2020 MeHI awarded $60,000 to Leuko to work with the …
News
classic
The Massachusetts eHealth Institute (MeHI), the lead agency for the Massachusetts Digital Health Ecosystem, is seeking digital health startups with a presence in the U.S. to compete in the Massachusetts …
We are very excited to welcome our first USA ecosystem: the Massachusetts Digital Health Ecosystem. Read this interview with Katie Green, Senior Program Manager, Innovation at MeHI. Who are the …